InsiderClue
Insiders · Profile

Redmile Group, LLC

10% owner at Attovia Therapeutics · 10% owner at ADC Therapeutics · Director at FATE THERAPEUTICS · and 6 more. Filing since 25 Sep 2018. CIK 0001425738

ATTO Attovia Therapeutics, Inc. 10% owner · 2 trades ADCT ADC Therapeutics SA 10% owner · 11 trades FATE FATE THERAPEUTICS INC Director · 11 trades STTK Shattuck Labs, Inc. Director · 3 trades ABSI Absci Corp Director · 2 trades TRDA Entrada Therapeutics, Inc. 10% owner · 1 trade IVVD Invivyd, Inc. 10% owner · 1 trade APRE Aprea Therapeutics, Inc. 10% owner · 2 trades NGNE Neurogene Inc. 10% owner · 7 trades
Company
Date
Role
Action
Shares
Amount
Of holding
ATTO Attovia Therapeutics, Inc.
6 Aug 2026
10% owner
Bought
400,000
$6.80M
51.1%
ATTO Attovia Therapeutics, Inc.
6 Aug 2026
10% owner
Bought
200,000
$3.40M
25.5%
ADCT ADC Therapeutics SA
2 Apr 2026
10% owner
Sold at will
2,634,506
$8.64M
17.2%
ADCT ADC Therapeutics SA
2 Apr 2026
10% owner
Sold at will
2,529,491
$8.29M
19.8%
ADCT ADC Therapeutics SA
1 Apr 2026
10% owner
Sold at will
169,265
$643.04K
1.1%
ADCT ADC Therapeutics SA
1 Apr 2026
10% owner
Sold at will
162,517
$617.40K
1.3%
ADCT ADC Therapeutics SA
31 Mar 2026
10% owner
Sold at will
196,229
$736.25K
1.3%
ADCT ADC Therapeutics SA
31 Mar 2026
10% owner
Sold at will
188,407
$706.90K
1.4%
FATE FATE THERAPEUTICS INC
20 Dec 2024
Director
Bought
397,964
$668.58K
3.2%
FATE FATE THERAPEUTICS INC
20 Dec 2024
Director
Sold at will
341,633
$573.94K
2.7%
ADCT ADC Therapeutics SA
11 Dec 2024
10% owner
Bought
100,000
$304.50K
0.8%
ADCT ADC Therapeutics SA
11 Dec 2024
10% owner
Bought
100,000
$304.50K
0.6%
STTK Shattuck Labs, Inc.
4 Dec 2024
Director
Sold at will
133,371
$166.71K
2.4%
STTK Shattuck Labs, Inc.
4 Dec 2024
Director
Bought
133,371
$166.71K
2.5%
ADCT ADC Therapeutics SA
4 Dec 2024
10% owner
Sold at will
25,352
$52.48K
0.2%
ADCT ADC Therapeutics SA
1 Jul 2024
10% owner
Bought
400,000
$1.12M
3.2%
ADCT ADC Therapeutics SA
1 Jul 2024
10% owner
Bought
400,000
$1.12M
2.6%
ABSI Absci Corp
1 Mar 2024
Director
Bought
222,222
$1,000.00K
2.8%
FATE FATE THERAPEUTICS INC
26 Dec 2023
Director
Bought
44,630
$166.02K
0.3%
FATE FATE THERAPEUTICS INC
21 Apr 2023
Director
Bought
256,639
$1.59M
2.0%
FATE FATE THERAPEUTICS INC
20 Apr 2023
Director
Bought
20,000
$119.80K
0.2%
FATE FATE THERAPEUTICS INC
14 Apr 2023
Director
Sold at will
302,339
$1.77M
2.3%
FATE FATE THERAPEUTICS INC
14 Apr 2023
Director
Bought
25,700
$154.20K
0.2%
TRDA Entrada Therapeutics, Inc.
2 Nov 2021
10% owner
Bought
1,000,000
$20.00M
105%
IVVD Invivyd, Inc.
10 Aug 2021
10% owner
Bought
1,470,000
$24.99M
76.5%
ABSI Absci Corp
26 Jul 2021
Director
Bought
1,875,000
$30.00M
30.5%
FATE FATE THERAPEUTICS INC
8 Jan 2021
Director
Bought
327,485
$28.00M
2.6%
APRE Aprea Therapeutics, Inc.
28 Dec 2020
10% owner
Sold, plan not stated
500,000
$2.79M
22.0%
STTK Shattuck Labs, Inc.
14 Oct 2020
Director
Bought
3,441,176
$59.67M
158%
FATE FATE THERAPEUTICS INC
11 Jun 2020
Director
Bought
1,412,928
$40.00M
12.6%
NGNE Neurogene Inc.
2 Apr 2020
10% owner
Bought
39,300
$446.96K
1.0%
NGNE Neurogene Inc.
2 Apr 2020
10% owner
Sold, plan not stated
9,834
$111.21K
0.2%
NGNE Neurogene Inc.
1 Apr 2020
10% owner
Bought
42,500
$471.63K
1.1%
NGNE Neurogene Inc.
1 Apr 2020
10% owner
Sold, plan not stated
9,834
$108.94K
0.2%
NGNE Neurogene Inc.
31 Mar 2020
10% owner
Bought
30,000
$309.39K
0.8%
NGNE Neurogene Inc.
30 Mar 2020
10% owner
Bought
32,500
$322.91K
0.8%
NGNE Neurogene Inc.
27 Mar 2020
10% owner
Bought
50,000
$460.40K
1.3%
APRE Aprea Therapeutics, Inc.
7 Oct 2019
10% owner
Bought
400,000
$6.00M
21.4%
FATE FATE THERAPEUTICS INC
16 Sep 2019
Director
Bought
857,143
$15.00M
8.3%
FATE FATE THERAPEUTICS INC
25 Sep 2018
Director
Bought
3,703,704
$50.00M
55.6%
40 decisions on file.